[Federal Register Volume 60, Number 225 (Wednesday, November 22, 1995)] [Notices] [Pages 57875-57876] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-28442] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Meeting of the Advisory Committee to the Director, NIH Pursuant to Public Law 92-463, notice is hereby given of the meeting of the Advisory Committee to the Director, NIH, December 7, 1995, Conference Room 10, Building 31, National Institutes of Health, Bethesda, Maryland 20892. The entire meeting will be open to the public from 8:30 a.m. to adjournment. The topics proposed for discussion include (1) Report from the Recombinant DNA Ad Hoc Committee; (2) Report and Recommendations from the Panel to Assesses the NIH Investment in Research on Gene Therapy; (3) Report from the Economics Roundtable; (4) Status Report from the Clinical Research Panel; and (5) Preliminary Report on the Study of Options Regarding the Clinical Center. Attendance by the public will be limited to space available. Ms. Janice Ramsden, Program Assistant, Office of the Deputy Director, National Institutes of Health, 1 Center [[Page 57876]] Drive MSC 0159, Bethesda, Maryland 20892-0159, telephone (301) 496- 0959, fax (301) 496-7451, will furnish the meeting agenda, roster of committee members, and substantive program information upon request. Any individual who requires special assistance, such as sign language interpretation or other reasonable accommodations, should contact Ms. Ramsden no later than November 28, 1995. Dated: November 13, 1995. Margery G. Grubb, Senior Committee Management Specialist, National Institutes of the Health. [FR Doc. 95-28442 Filed 11-21-95; 8:45 am] BILLING CODE 4140-01-M